APO-RIVASTIGMINE PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

rivastigmine, Quantity: 9 mg

Dostupné z:

Arrotex Pharmaceuticals Pty Ltd

INN (Medzinárodný Name):

Rivastigmine

Forma lieku:

Drug delivery system, transdermal

Zloženie:

Excipient Ingredients: acrylates copolymer; ethyl acetate; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer; methylated trimethylated silica

Spôsob podávania:

Transdermal

Počet v balení:

7 transdermal drug delivery systems, 30 transdermal drug delivery systems

Typ predpisu:

(S4) Prescription Only Medicine

Terapeutické indikácie:

APO-RIVASTIGMINE is indicated for the treatment of patients with mild to moderate dementia of the Alzheimer's type.

Prehľad produktov:

Visual Identification: Circular 5cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 4.6 mg/24 h"; Container Type: Sachet; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stav Autorizácia:

Licence status A

Dátum Autorizácia:

2016-01-12